Buparlisib plus fulvestrant versus placebo plus fulvestrant in postmenopausal, hormone receptor-positive, HER2-negative, advanced breast cancer (BELLE-2): a randomised, double-blind, placebo-controlled, phase 3 trial.
| Image |  |
|---|---|
| Description | scientific article |
| Author/s |
author: Javier Cortes Peter Vuylsteke Michelino De Laurentiis Mark Clemons Seock-Ah Im Hiroji Iwata Norikazu Masuda |
| Publication date | May 30, 2017 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |